Health Canada — Medical Devices · Canada · 2024-07-24 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: Philips Respironics has become aware that Trilogy EVO and Trilogy EV300 devices do not comply with the obstruction alarm requirements specified within ISO 80601-2-12 clause 201.12.4.108 and ISO 80601-2-72 clause 201.12.4.107. The standards specify that the maximum delay from obstruction to alarm shall be no more than 2 breath cycles or 5 seconds, whichever is greater. The current obstruction alarm delay for these devices has been measured up to 65 seconds in certain bench test conditions. This is a delay potentially 60 seconds greater than required by the standards. Recall start date: July 1, 2024
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.